AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33756250 — intervention group
Group type: EXPERIMENTAL
Intervention: BDC supplementation (150 mg/kg)
Number of subjects: 320
Study 33756250 — intervention group
Group type: COMPARATOR
Intervention: LPS challenge
Number of subjects: 320
Study 32620917 — intervention group
Group type: EXPERIMENTAL
Intervention: dMMR CRCs
Number of subjects: 381
Study 32620917 — intervention group
Group type: EXPERIMENTAL
Intervention: MLH1me+ dMMR CRCs
Number of subjects: 381
Study 32620917 — intervention group
Group type: EXPERIMENTAL
Intervention: dMMR CRCs bearing receptor tyrosine kinase fusion
Number of subjects: 381
Study 34308666 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Generated Identification Codes (SGIC) group
Number of subjects: 1844
Study 34308666 — intervention group
Group type: COMPARATOR
Intervention: Anonymous control group
Number of subjects: 1844
Study 33492349 — intervention group
Group type: EXPERIMENTAL
Intervention: Assistive technology and telecare (ATT)
Number of subjects: 495
Study 33492349 — intervention group
Group type: COMPARATOR
Intervention: Limited control of appropriate ATT
Number of subjects: 495
Study 36114862 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy (RT)
Number of subjects: 4324
Study 36114862 — intervention group
Group type: COMPARATOR
Intervention: No adjuvant radiotherapy (RT)
Number of subjects: 4324
Study 34099018 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupressure for 12 months
Number of subjects: 480
Study 34099018 — intervention group
Group type: COMPARATOR
Intervention: Blank control
Number of subjects: 480
Study 36385793 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual self-assessment card
Number of subjects: 405
Study 36174744 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose intravenous hydroxocobalamin (IV-HOC), 5-gram dose
Number of subjects: 20
Study 36174744 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline solution)
Number of subjects: 20
Study 32977049 — intervention group
Group type: EXPERIMENTAL
Intervention: Females
Number of subjects: 318
Study 32977049 — intervention group
Group type: EXPERIMENTAL
Intervention: Males
Number of subjects: 318
Study 35984578 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive feedback during modified Trier Social Stress Test
Number of subjects: 60
Study 35984578 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative feedback during modified Trier Social Stress Test
Number of subjects: 60
Study 35984578 — intervention group
Group type: COMPARATOR
Intervention: Cardiac vagal control (CVC) measures
Number of subjects: 60
Study 33781596 — intervention group
Group type: EXPERIMENTAL
Intervention: ONCAB group (1056 patients)
Number of subjects: 2103
Study 33781596 — intervention group
Group type: COMPARATOR
Intervention: OPCAB group (1047 patients)
Number of subjects: 2103
Study 32699107 — intervention group
Group type: EXPERIMENTAL
Intervention: Women in rural areas
Number of subjects: 805
Study 32699107 — intervention group
Group type: COMPARATOR
Intervention: Men in rural areas
Number of subjects: 805
Study 32699107 — intervention group
Group type: COMPARATOR
Intervention: Women in urban areas
Number of subjects: 805
Study 32699107 — intervention group
Group type: EXPERIMENTAL
Intervention: Men in urban areas
Number of subjects: 805
Study 32699107 — intervention group
Group type: COMPARATOR
Intervention: Rural women vs rural men
Number of subjects: 805
Study 32699107 — intervention group
Group type: COMPARATOR
Intervention: Urban women vs urban men
Number of subjects: 805
Study 32699107 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall diabetes prevalence
Number of subjects: 805
Study 33154039 — intervention group
Group type: EXPERIMENTAL
Intervention: REACH (tailored text messaging intervention)
Number of subjects: 506
Study 33154039 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 506
Study 32563787 — intervention group
Group type: EXPERIMENTAL
Intervention: Mupirocin
Number of subjects: 62
Study 32563787 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine
Number of subjects: 62
Study 32563787 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 62
Study 37904182 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based mobile apps
Number of subjects: 60
Study 33676474 — intervention group
Group type: EXPERIMENTAL
Intervention: Members of the sports organization
Number of subjects: 3015
Study 33676474 — intervention group
Group type: COMPARATOR
Intervention: Controls (matched general population)
Number of subjects: 3015
Study 32930649 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital breast tomosynthesis combined with two-dimensional synthetic mammography (DBT+SM)
Number of subjects: 28749
Study 32930649 — intervention group
Group type: COMPARATOR
Intervention: Digital mammography (DM)
Number of subjects: 28749
Study 35021263 — intervention group
Group type: EXPERIMENTAL
Intervention: Earplugs and eye masks during the night (experimental group)
Number of subjects: 84
Study 35021263 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 84
Study 35021263 — intervention group
Group type: COMPARATOR
Intervention: Comparison of experimental and control groups on RCSQ and ICDSC scores
Number of subjects: 84
Study 35614848 — intervention group
Group type: COMPARATOR
Intervention: BMI
Number of subjects: 547
Study 33538306 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Me, Healthy We (HMHW) social marketing campaign
Number of subjects: 48
Study 35175317 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan (194/206 mg)
Number of subjects: 19
Study 35175317 — intervention group
Group type: COMPARATOR
Intervention: Sitagliptin
Number of subjects: 19
Study 33069714 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtered air + allergen
Number of subjects: 11
Study 33069714 — intervention group
Group type: EXPERIMENTAL
Intervention: Diesel exhaust (DE) + allergen
Number of subjects: 11
Study 33069714 — intervention group
Group type: COMPARATOR
Intervention: Filtered air + saline
Number of subjects: 11
Study 32657457 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrrolate up to 4.5 mg/d
Number of subjects: 28
Study 32657457 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 35726548 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc oxide‐eugenol
Number of subjects: 105
Study 35726548 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium hydroxide
Number of subjects: 105
Study 35726548 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineral trioxide aggregate
Number of subjects: 105
Study 34098951 — intervention group
Group type: EXPERIMENTAL
Intervention: TdaP5-IPV (n = 67)
Number of subjects: 154
Study 34098951 — intervention group
Group type: EXPERIMENTAL
Intervention: TdaP3-IPV (n = 63)
Number of subjects: 154
Study 34098951 — intervention group
Group type: COMPARATOR
Intervention: Unvaccinated mothers (n = 45)
Number of subjects: 154
Study 32653022 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral pulsed jet lavage (irrigated group)
Number of subjects: 30
Study 32653022 — intervention group
Group type: COMPARATOR
Intervention: Standardized vertebroplasty without irrigation (control group)
Number of subjects: 30
Study 35708706 — intervention group
Group type: EXPERIMENTAL
Intervention: Port Delivery System (PDS) with ranibizumab, 100 mg/mL, fixed refill exchanges every 24 weeks
Number of subjects: 415
Study 35708706 — intervention group
Group type: COMPARATOR
Intervention: Intravitreal ranibizumab injections, 0.5 mg, every 4 weeks
Number of subjects: 415
Study 35708706 — intervention group
Group type: EXPERIMENTAL
Intervention: Port Delivery System (PDS)
Number of subjects: 415
Study 35708706 — intervention group
Group type: COMPARATOR
Intervention: Concurrent fellow-eye injections
Number of subjects: 415
Study 33904284 — intervention group
Group type: EXPERIMENTAL
Intervention: Simodont virtual simulation system
Number of subjects: 20
Study 33904284 — intervention group
Group type: COMPARATOR
Intervention: Conventional phantom‐simulator system
Number of subjects: 20
Study 33904284 — intervention group
Group type: EXPERIMENTAL
Intervention: Simodont virtual simulation system followed by conventional phantom‐simulator system
Number of subjects: 20
Study 33904284 — intervention group
Group type: COMPARATOR
Intervention: Conventional phantom‐simulator system followed by Simodont virtual simulation system
Number of subjects: 20
Study 33904284 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional phantom‐simulator system after using Simodont virtual simulation system
Number of subjects: 20
Study 32228238 — intervention group
Group type: EXPERIMENTAL
Intervention: Text messaging intervention for hypertension management
Number of subjects: 333
Study 35734974 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen/oxygen inhalation for 13 weeks
Number of subjects: 43
Study 35734974 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen/oxygen inhalation
Number of subjects: 43
Study 35734974 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen incubation (20%)
Number of subjects: 43
Study 35734974 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen treatment
Number of subjects: 43
Study 34081385 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 g glucose to induce PBH
Number of subjects: 10
Study 34081385 — intervention group
Group type: COMPARATOR
Intervention: Aspartame to leave glycaemia unchanged
Number of subjects: 10
Study 35437929 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan (200 mg/day)
Number of subjects: 64
Study 35437929 — intervention group
Group type: COMPARATOR
Intervention: Valsartan (160 mg/day)
Number of subjects: 64
Study 32656739 — intervention group
Group type: EXPERIMENTAL
Intervention: Oncokompas eHealth application
Number of subjects: 625
Study 32656739 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 625
Study 35196474 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized social cognition (SC) module + non-SC module (experimental group, n=28)
Number of subjects: 45
Study 35196474 — intervention group
Group type: COMPARATOR
Intervention: Non-SC module only (control group, n=26)
Number of subjects: 45
Study 34312964 — intervention group
Group type: EXPERIMENTAL
Intervention: Single assistant robotic surgery (SA-RS)
Number of subjects: 0
Study 34312964 — intervention group
Group type: COMPARATOR
Intervention: Dual assistant robotic surgery (D-RS)
Number of subjects: 0
Study 32910197 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen/cell group (hUC-MSC-laden collagen hydrogel intramyocardial injection)
Number of subjects: 50
Study 32910197 — intervention group
Group type: EXPERIMENTAL
Intervention: Cell group (hUC-MSCs alone)
Number of subjects: 50
Study 32910197 — intervention group
Group type: COMPARATOR
Intervention: Control group (CABG alone)
Number of subjects: 50
Study 32910197 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 50
Study 35430680 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive model for acute kidney injury (AKI) using clinical features and machine learning.
Number of subjects: 996
Study 35430680 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting AKI and severe AKI.
Number of subjects: 996
Study 33347912 — intervention group
Group type: EXPERIMENTAL
Intervention: Competition task (rock-paper-scissors game)
Number of subjects: 0
Study 33347912 — intervention group
Group type: COMPARATOR
Intervention: Control task (assessing facial expressions)
Number of subjects: 0
Study 32465460 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise-based inpatient cardiac rehabilitation (CR)
Number of subjects: 435
Study 32465460 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with ICM
Number of subjects: 435
Study 32465460 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients after myocarditis
Number of subjects: 435
Study 32465460 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with atrial fibrillation
Number of subjects: 435
Study 32465460 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with at least intermittent opening of aortic valve
Number of subjects: 435
Study 33527576 — intervention group
Group type: EXPERIMENTAL
Intervention: L-menthol (160 mg)
Number of subjects: 220
Study 33527576 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study 33527576 — intervention group
Group type: EXPERIMENTAL
Intervention: L-menthol (160 mg) and Placebo
Number of subjects: 220
Study 32458567 — intervention group
Group type: EXPERIMENTAL
Intervention: Treat All
Number of subjects: 3405
Study 32458567 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SoC)
Number of subjects: 3405
Study 35561721 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal human antitoxin
Number of subjects: 272
Study 35561721 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 272
Study 35561721 — intervention group
Group type: EXPERIMENTAL
Intervention: Human intramuscular antitoxin
Number of subjects: 272
Study 35561721 — intervention group
Group type: COMPARATOR
Intervention: Equine intramuscular antitoxin
Number of subjects: 272
Study 35561721 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal group
Number of subjects: 272
Study 32688143 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation intervention (aerobic and resistance exercise, cognitive training, dual-task training, sleep hygiene and nutritional guidance)
Number of subjects: 31
Study 32688143 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation intervention
Number of subjects: 31
Study 32688143 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 31
Study 36041469 — intervention group
Group type: EXPERIMENTAL
Intervention: Flipped Classroom (FC)
Number of subjects: 244
Study 36041469 — intervention group
Group type: COMPARATOR
Intervention: Traditional Didactics (TD)
Number of subjects: 244
Study 33358790 — intervention group
Group type: EXPERIMENTAL
Intervention: High rate of milk replacer (HMR; 29.1% CP, 17.3% fat; 1.5% of BW as DM for wk 1, 2% of BW as DM wk 2‐5, 1% of BW as DM wk 6) plus conventional starter; n = 12 calves
Number of subjects: 45
Study 33358790 — intervention group
Group type: EXPERIMENTAL
Intervention: High rate of milk replacer (HMR) plus high‐CP starter (HCS; 26% CP, DM basis); n = 14 calves
Number of subjects: 45
Study 33358790 — intervention group
Group type: COMPARATOR
Intervention: High rate of milk replacer (HMR) plus conventional starter (CCS; 21.5% CP, DM basis); n = 12 calves
Number of subjects: 45
Study 33358790 — intervention group
Group type: EXPERIMENTAL
Intervention: High rate of milk replacer (HMR); n = 12 calves
Number of subjects: 45
Study 33358790 — intervention group
Group type: EXPERIMENTAL
Intervention: High rate of milk replacer (HMR + HCS); n = 14 calves
Number of subjects: 45
Study 33358790 — intervention group
Group type: EXPERIMENTAL
Intervention: High rate of milk replacer (HMR treatments); n = 12 calves
Number of subjects: 45
Study 33358790 — intervention group
Group type: COMPARATOR
Intervention: Low rate of milk replacer (LMR; 20.6% CP, 21.7% fat; 1.25% of BW as DM) plus conventional starter (CCS; 21.5% CP, DM basis); n = 11 calves
Number of subjects: 45
Study 36083793 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic cardiosphere-derived cell (CDC) therapy (20 × 10^6 CDCs)
Number of subjects: 29
Study 36083793 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic cardiosphere-derived cell (CDC) therapy with cyclosporine (2.5 mg/kg iv and 100 mg/day po)
Number of subjects: 29
Study 36083793 — intervention group
Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 29
Study 32071281 — intervention group
Group type: EXPERIMENTAL
Intervention: Treat-to-target approach in PsA
Number of subjects: 0
Study 32071281 — intervention group
Group type: COMPARATOR
Intervention: Tight Control of Psoriatic Arthritis study
Number of subjects: 0
Study 32942924 — intervention group
Group type: EXPERIMENTAL
Intervention: HH subjects with arthritis
Number of subjects: 119
Study 34498497 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibling support group focused on autism spectrum disorder
Number of subjects: 0
Study 34498497 — intervention group
Group type: COMPARATOR
Intervention: Similar group without a focus on autism spectrum disorder
Number of subjects: 0
Study 33781617 — intervention group
Group type: EXPERIMENTAL
Intervention: Community health worker-led multicomponent intervention (health education, monthly telephone follow-ups, navigation assistance)
Number of subjects: 387
Study 33781617 — intervention group
Group type: COMPARATOR
Intervention: Control group (waitlist)
Number of subjects: 387
Study 33781617 — intervention group
Group type: EXPERIMENTAL
Intervention: Community health worker-led multicomponent intervention
Number of subjects: 387
Study 35779560 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin (40 mg once daily if <100 kg, 40 mg twice daily if ≥100 kg) for 21 days
Number of subjects: 219
Study 35779560 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (no enoxaparin)
Number of subjects: 219
Study 35779560 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 219
Study 35779560 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 219
Study 33121228 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine (NE) infusion (8 µg/min)
Number of subjects: 62
Study 33121228 — intervention group
Group type: COMPARATOR
Intervention: Phenylephrine (PE) infusion (100 µg/min)
Number of subjects: 62
Study 33317488 — intervention group
Group type: EXPERIMENTAL
Intervention: ready4life coaching program
Number of subjects: 1318
Study 33317488 — intervention group
Group type: COMPARATOR
Intervention: assessment only control group
Number of subjects: 1318
Study 35224034 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based Baduanjin exercise (5 times a week for 12 weeks)
Number of subjects: 114
Study 35224034 — intervention group
Group type: COMPARATOR
Intervention: Moderate intensity aerobic walking (5 times a week for 12 weeks)
Number of subjects: 114
Study 35222890 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramedullary nailing (IMN)
Number of subjects: 60
Study 35222890 — intervention group
Group type: COMPARATOR
Intervention: Locking proximal humeral plate (LPHP)
Number of subjects: 60
Study 33926403 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 1-59
Number of subjects: 3350
Study 33926403 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 1-11
Number of subjects: 3350
Study 33926403 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3350
Study 32620262 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose TXA (50 mg kg−1 followed by 5 mg kg−1 h−1)
Number of subjects: 68
Study 32620262 — intervention group
Group type: COMPARATOR
Intervention: Low-dose TXA (10 mg kg−1 followed by 5 mg kg−1 h−1)
Number of subjects: 68
Study 33111247 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training intervention
Number of subjects: 62
Study 33111247 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control)
Number of subjects: 62
Study 36377259 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared Decision Making (SDM) intervention
Number of subjects: 158
Study 36377259 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 158
Study 34235608 — intervention group
Group type: EXPERIMENTAL
Intervention: ConnectedCancerCare (CCC)
Number of subjects: 66
Study 34235608 — intervention group
Group type: COMPARATOR
Intervention: Static online survivorship care plan (control)
Number of subjects: 66
Study 32186106 — intervention group
Group type: EXPERIMENTAL
Intervention: Gua Sha therapy
Number of subjects: 44
Study 32186106 — intervention group
Group type: COMPARATOR
Intervention: Sham scraping
Number of subjects: 44
Study 32186106 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study 36494329 — intervention group
Group type: EXPERIMENTAL
Intervention: SOM3355 (bevantolol hydrochloride) 200 mg twice daily
Number of subjects: 32
Study 36494329 — intervention group
Group type: EXPERIMENTAL
Intervention: SOM3355 (bevantolol hydrochloride)
Number of subjects: 32
Study 36494329 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 33067856 — intervention group
Group type: EXPERIMENTAL
Intervention: Drink Less app (recommended via email)
Number of subjects: 5562
Study 33067856 — intervention group
Group type: COMPARATOR
Intervention: NHS alcohol advice webpage (comparator)
Number of subjects: 5562
Study 32199156 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol dose of 0.45 g/kg
Number of subjects: 160
Study 32199156 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol dose of 0.65 g/kg
Number of subjects: 160
Study 32199156 — intervention group
Group type: COMPARATOR
Intervention: No exposure to in-vehicle alcohol feedback device
Number of subjects: 160
Study 32199156 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to in-vehicle alcohol feedback device
Number of subjects: 160
Study 34287079 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-resident completed suicides
Number of subjects: 303
Study 34287079 — intervention group
Group type: EXPERIMENTAL
Intervention: Thematic analysis of 30 death notes
Number of subjects: 303
Study 34287079 — intervention group
Group type: COMPARATOR
Intervention: Comparison with resident cases
Number of subjects: 303
Study 32999419 — intervention group
Group type: COMPARATOR
Intervention: Breastfeeding (never breastfed)
Number of subjects: 230
Study 32999419 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer breastfeeding duration
Number of subjects: 230
Study 32999419 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal uncontrolled eating
Number of subjects: 230
Study 32999419 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal emotional eating
Number of subjects: 230
Study 36307858 — intervention group
Group type: EXPERIMENTAL
Intervention: Active HD-tDCS
Number of subjects: 58
Study 36307858 — intervention group
Group type: COMPARATOR
Intervention: Sham HD-tDCS
Number of subjects: 58
Study 33892983 — intervention group
Group type: EXPERIMENTAL
Intervention: Microplanning verification process
Number of subjects: 36
Study 32221819 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary peer educators
Number of subjects: 966
Study 32221819 — intervention group
Group type: COMPARATOR
Intervention: Peer nominated peer educators
Number of subjects: 966
Study 34467621 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary diversity score (DDS) derived from the Minimum Dietary Diversity for Women 10-item scale
Number of subjects: 390
Study 34467621 — intervention group
Group type: EXPERIMENTAL
Intervention: Wealth quintile as a social determinant of nutrition
Number of subjects: 390